Trending...
- Sober.Buzz the Sober Token : Ticker $BUZZ
- Global Families Turn to Young Travelers Concierge Amid Rising Safety Concerns in the U.S
- UIFCA Revolutionizes Financial Education with Elite Team of Investment Experts
Cogniclear VR, an innovative new virtual reality-based cognitive assessment tool developed by Virtuleap, is set to redefine how cognitive impairments are detected and monitored. Unlike traditional pen-and-paper tests, Cogniclear VR immerses users in realistic virtual environments to deliver more precise, objective evaluations of cognitive function.
LISBON, Portugal - nvtip -- Cogniclear VR, an innovative new virtual reality-based cognitive assessment tool developed by Virtuleap, is set to redefine how cognitive impairments are detected and monitored. Unlike traditional pen-and-paper tests, Cogniclear VR immerses users in realistic virtual environments to deliver more precise, objective evaluations of cognitive function.
Current screening methods like the MMSE or MoCA, though reliable, often miss the earliest signs of cognitive decline. Cogniclear VR fills this gap by offering an advanced, ecologically valid approach that reflects real-world tasks, enabling earlier and more accurate detection of cognitive impairments. This cutting-edge system equips healthcare providers with detailed reports that eliminate subjective interpretation, ensuring clearer insights into a patient's cognitive health. Cogniclear VR features 14 exercises across eight cognitive domains, including memory, attention, problem-solving, and motor control, all designed to simulate daily challenges. The result is a more relevant and impactful assessment of cognitive abilities.
More on nvtip.com
"Cogniclear VR was incubated as part of Roche's 'Building Together Tomorrow' dementia program, which Virtuleap joined in spring 2022. Since then, it has undergone two years of rigorous development, in close collaboration with our hospital partners, to reach this pivotal launch," said Amir Bozorgzadeh, CEO at Virtuleap. "Cogniclear VR is positioned to be a key tool in early cognitive diagnosis and ongoing care, helping individuals maintain independence and quality of life."
Designed for accessibility, Cogniclear VR ensures that users of all technological backgrounds can engage easily with the platform, thanks to its intuitive onboarding process. As a VR-based tool, Cogniclear VR creates an ecologically valid, multisensory environment that immerses users in realistic scenarios, engaging the full body and capturing observational data that traditional assessments miss. Whether used in clinics or remotely, this advanced screening approach empowers clinicians to monitor cognitive changes over time, enabling earlier, more informed intervention when needed.
"When I began developing clinical VR applications in the mid-90s, the first area where I recognized its immense potential was in neurocognitive assessment and rehabilitation. Since then, research, science, and development in this field have steadily progressed, addressing the needs of individuals with central nervous system damage or dysfunction. Nearly 30 years later, Virtuleap embodies what makes sense in this area." said Albert "Skip" Rizzo, PhD, Director of Medical Virtual Reality at USC's Institute for Creative Technologies.
More on nvtip.com
He continued: "They have developed high-fidelity VR simulations for cognitive testing and training that are scientifically informed, reasonably priced, and engaging for users. The days of relying solely on neuropsychological tools that have seen little advancement since the mid-20th century are over. Virtuleap offers cognitive training and evaluation activities that immerse users in rehabilitative exercises, driving cognitive activation while a backend system quantifies performance and adjusts challenge levels. These tools hold great potential for making a positive impact in people's lives!"
Cogniclear VR also complements Enhance VR, Virtuleap's cognitive training library, which includes 15 gamified exercises based on validated neuropsychological tools. These exercises target seven key cognitive abilities and have been proven effective in various studies, including pilot research on young adults with ADHD and individuals with intellectual and developmental disabilities (IDD). Together, Cogniclear VR and Enhance VR offer a comprehensive approach to cognitive health, from assessment to continuous training.
Learn more at https://virtuleap.com/
Current screening methods like the MMSE or MoCA, though reliable, often miss the earliest signs of cognitive decline. Cogniclear VR fills this gap by offering an advanced, ecologically valid approach that reflects real-world tasks, enabling earlier and more accurate detection of cognitive impairments. This cutting-edge system equips healthcare providers with detailed reports that eliminate subjective interpretation, ensuring clearer insights into a patient's cognitive health. Cogniclear VR features 14 exercises across eight cognitive domains, including memory, attention, problem-solving, and motor control, all designed to simulate daily challenges. The result is a more relevant and impactful assessment of cognitive abilities.
More on nvtip.com
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Prism Bank's Delene Gilbert Speaks at 2025 Financial Brand Forum
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
"Cogniclear VR was incubated as part of Roche's 'Building Together Tomorrow' dementia program, which Virtuleap joined in spring 2022. Since then, it has undergone two years of rigorous development, in close collaboration with our hospital partners, to reach this pivotal launch," said Amir Bozorgzadeh, CEO at Virtuleap. "Cogniclear VR is positioned to be a key tool in early cognitive diagnosis and ongoing care, helping individuals maintain independence and quality of life."
Designed for accessibility, Cogniclear VR ensures that users of all technological backgrounds can engage easily with the platform, thanks to its intuitive onboarding process. As a VR-based tool, Cogniclear VR creates an ecologically valid, multisensory environment that immerses users in realistic scenarios, engaging the full body and capturing observational data that traditional assessments miss. Whether used in clinics or remotely, this advanced screening approach empowers clinicians to monitor cognitive changes over time, enabling earlier, more informed intervention when needed.
"When I began developing clinical VR applications in the mid-90s, the first area where I recognized its immense potential was in neurocognitive assessment and rehabilitation. Since then, research, science, and development in this field have steadily progressed, addressing the needs of individuals with central nervous system damage or dysfunction. Nearly 30 years later, Virtuleap embodies what makes sense in this area." said Albert "Skip" Rizzo, PhD, Director of Medical Virtual Reality at USC's Institute for Creative Technologies.
More on nvtip.com
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Dr. Dennis Jackson Brings Non-Operating Orthopaedic Sports and Emergency Medicine Expertise to Crovetti Orthopaedics and Sports Medicine
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
He continued: "They have developed high-fidelity VR simulations for cognitive testing and training that are scientifically informed, reasonably priced, and engaging for users. The days of relying solely on neuropsychological tools that have seen little advancement since the mid-20th century are over. Virtuleap offers cognitive training and evaluation activities that immerse users in rehabilitative exercises, driving cognitive activation while a backend system quantifies performance and adjusts challenge levels. These tools hold great potential for making a positive impact in people's lives!"
Cogniclear VR also complements Enhance VR, Virtuleap's cognitive training library, which includes 15 gamified exercises based on validated neuropsychological tools. These exercises target seven key cognitive abilities and have been proven effective in various studies, including pilot research on young adults with ADHD and individuals with intellectual and developmental disabilities (IDD). Together, Cogniclear VR and Enhance VR offer a comprehensive approach to cognitive health, from assessment to continuous training.
Learn more at https://virtuleap.com/
Source: Virtuleap
0 Comments
Latest on nvtip.com
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Mix Master AI Bartender Launches Web Platform, Revolutionizing Cocktail Creation
- Evolving Gaming Regulations: New Insights From Info-Tech Research Group Shows How IT Leaders Can Strengthen Compliance and Reduce Risk
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando
- Events by Dubsdread Expands Services to The Venue at Lake Lily
- London Gala Emphasizes Trade, FDI and Ongoing Cooperation